Department of Neurology and Center for Clinical Neuroscience Daping Hospital Third Military Medical University Chongqing 400042 ChinaChongqing Key Laboratory of Ageing and Brain Diseases Chongqing 400042 ChinaInstitute of Brain and Intelligence Third Military Medical University Chongqing 400042 China;
Department of Neurology and Center for Clinical Neuroscience Daping Hospital Third Military Medical University Chongqing 400042 ChinaChongqing Key Laboratory of Ageing and Brain Diseases Chongqing 400042 ChinaInstitute of Brain and Intelligence Third Military Medical University Chongqing 400042 China;
Department of Neurology and Center for Clinical Neuroscience Daping Hospital Third Military Medical University Chongqing 400042 ChinaChongqing Key Laboratory of Ageing and Brain Diseases Chongqing 400042 ChinaInstitute of Brain and Intelligence Third Military Medical University Chongqing 400042 China;
Department of Neurology and Center for Clinical Neuroscience Daping Hospital Third Military Medical University Chongqing 400042 ChinaChongqing Key Laboratory of Ageing and Brain Diseases Chongqing 400042 ChinaInstitute of Brain and Intelligence Third Military Medical University Chongqing 400042 China;
Department of Neurology and Center for Clinical Neuroscience Daping Hospital Third Military Medical University Chongqing 400042 ChinaChongqing Key Laboratory of Ageing and Brain Diseases Chongqing 400042 ChinaInstitute of Brain and Intelligence Third Military Medical University Chongqing 400042 China;
Department of Neurology and Center for Clinical Neuroscience Daping Hospital Third Military Medical University Chongqing 400042 ChinaChongqing Key Laboratory of Ageing and Brain Diseases Chongqing 400042 ChinaInstitute of Brain and Intelligence Third Military Medical University Chongqing 400042 China;
Alzheimer''s disease; amyloidβ; immunotherapy; β-secretase; γ-secretase; enzyme inhibitor; multi-target therapy; tertiary prevention strategy;